03/09/2020
8:24 AM | BioXcel Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/09/2020
7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2020
10:13 AM | BioXcel Therapeutics (Subject)
DNCA FINANCE (Filed by)
| Form SC 13D/A
| |
02/24/2020
8:30 AM | BioXcel Therapeutics (Subject)
DNCA FINANCE (Filed by)
| Form SC 13D/A
| |
02/20/2020
8:54 PM | BioXcel Therapeutics (Filer)
| Form 424B5
| |
02/20/2020
8:50 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2020
4:22 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
4:11 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2020
4:07 PM | BioXcel Therapeutics (Filer)
| Form 424B5
| |
02/18/2020
9:18 AM | BioXcel Therapeutics (Subject)
DNCA FINANCE (Filed by)
| Form SC 13D/A
| |
01/13/2020
8:12 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2019
4:06 PM | BioXcel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/14/2019
8:15 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2019
7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2019
12:42 AM | BioXcel Therapeutics (Filer)
| Form 424B5
| |
09/27/2019
4:31 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2019
3:58 PM | BioXcel Therapeutics (Filer)
| Form 424B5
| |
09/25/2019
3:20 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2019
4:38 PM | BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2019
3:26 PM | BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2019
3:16 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2019
3:17 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2019
3:15 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2019
3:15 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2019
8:16 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2019
7:06 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2019
8:29 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/19/2019
8:07 PM | BioXcel Therapeutics (Issuer)
Votruba Michal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2019
4:05 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2019
8:01 PM | BioXcel Therapeutics (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
8:00 PM | BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
7:59 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
5:10 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2019
8:28 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2019
8:18 AM | BioXcel Therapeutics (Filer)
| Form 424B5
| |
05/20/2019
8:04 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2019
7:17 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2019
11:16 PM | BioXcel Therapeutics (Filer)
| Form EFFECT
| |
04/01/2019
4:30 PM | BioXcel Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/01/2019
4:20 PM | BioXcel Therapeutics (Filer)
| Form DEF 14A
| |
04/01/2019
4:15 PM | BioXcel Therapeutics (Filer)
| Form RW
| |
03/25/2019
3:45 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2019
4:38 PM | BioXcel Therapeutics (Issuer)
Votruba Michal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2019
4:35 PM | BioXcel Therapeutics (Issuer)
Votruba Michal (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/14/2019
3:45 PM | BioXcel Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/12/2019
4:21 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2019
3:38 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2019
3:42 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2019
3:19 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
6:33 AM | BioXcel Corp (Filed by)
BioXcel Therapeutics (Subject)
| Form SC 13G
| |
02/04/2019
4:03 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2019
3:27 PM | BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
12/27/2018
3:11 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2018
4:08 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2018
10:56 AM | BioXcel Therapeutics (Filer)
| Form CT ORDER
| |
12/14/2018
3:30 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2018
3:11 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2018
8:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2018
4:50 PM | BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2018
4:34 PM | BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2018
5:04 AM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2018
4:05 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2018
9:22 AM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2018
8:49 AM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:36 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:35 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
3:17 PM | BioXcel Therapeutics (Issuer)
Nandabalan Krishnan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
3:10 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
1:31 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
1:30 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2018
7:44 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2018
6:47 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2018
6:35 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2018
3:30 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2018
7:15 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2018
3:20 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2018
9:06 AM | BioXcel Therapeutics (Subject)
DNCA FINANCE (Filed by)
| Form SC 13D
| |
08/23/2018
4:09 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2018
3:13 PM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2018
3:02 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2018
4:20 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2018
3:17 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2018
3:01 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2018
3:59 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2018
3:20 PM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2018
3:19 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2018
3:12 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2018
9:11 AM | BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G
| |
03/13/2018
4:13 PM | BioXcel Therapeutics (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2018
4:12 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2018
4:12 PM | BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2018
4:11 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2018
4:10 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/09/2018
2:35 PM | BioXcel Therapeutics (Filer)
| Form 424B4
| |
03/08/2018
12:10 PM | BioXcel Therapeutics (Filer)
| Form CT ORDER
| |
03/07/2018
11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT
| |
03/07/2018
5:35 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2018
5:27 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2018
5:26 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2018
5:25 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
